JPS52108027A - Anticarcinogen - Google Patents

Anticarcinogen

Info

Publication number
JPS52108027A
JPS52108027A JP2522576A JP2522576A JPS52108027A JP S52108027 A JPS52108027 A JP S52108027A JP 2522576 A JP2522576 A JP 2522576A JP 2522576 A JP2522576 A JP 2522576A JP S52108027 A JPS52108027 A JP S52108027A
Authority
JP
Japan
Prior art keywords
anticarcinogen
anticarcinogens
remarkable
solid tumor
high safety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2522576A
Other languages
English (en)
Japanese (ja)
Other versions
JPS54962B2 (enExample
Inventor
Setsuo Takeuchi
Mutsuyuki Kochi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RIKEN
Original Assignee
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RIKEN filed Critical RIKEN
Priority to JP2522576A priority Critical patent/JPS52108027A/ja
Priority to GB8910/77A priority patent/GB1573965A/en
Priority to FR7706762A priority patent/FR2343475A1/fr
Priority to CA273,441A priority patent/CA1093971A/en
Priority to AU23073/77A priority patent/AU499475B2/en
Priority to NLAANVRAGE7702535,A priority patent/NL172917C/xx
Priority to DE2710327A priority patent/DE2710327C3/de
Priority to BE175645A priority patent/BE852283A/xx
Publication of JPS52108027A publication Critical patent/JPS52108027A/ja
Publication of JPS54962B2 publication Critical patent/JPS54962B2/ja
Priority to US07/265,415 priority patent/US4983636A/en
Granted legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2522576A 1976-03-09 1976-03-09 Anticarcinogen Granted JPS52108027A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP2522576A JPS52108027A (en) 1976-03-09 1976-03-09 Anticarcinogen
GB8910/77A GB1573965A (en) 1976-03-09 1977-03-02 Carcinostatic compositions
FR7706762A FR2343475A1 (fr) 1976-03-09 1977-03-08 Composition carcinostatique et procede de traitement d'une maladie maligne
CA273,441A CA1093971A (en) 1976-03-09 1977-03-08 Carcinostatic composition and method of treating a malignant condition
NLAANVRAGE7702535,A NL172917C (nl) 1976-03-09 1977-03-09 Werkwijze voor het bereiden van een geneesmiddel tegen kanker.
AU23073/77A AU499475B2 (en) 1976-03-09 1977-03-09 Anti-malignant tumor composition
DE2710327A DE2710327C3 (de) 1976-03-09 1977-03-09 Verwendung von Benzaldehyd
BE175645A BE852283A (fr) 1976-03-09 1977-03-09 Compositions carcinostatiques et leur utilisation
US07/265,415 US4983636A (en) 1976-03-09 1988-10-31 Composition and method of treating selected malignant conditions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2522576A JPS52108027A (en) 1976-03-09 1976-03-09 Anticarcinogen

Publications (2)

Publication Number Publication Date
JPS52108027A true JPS52108027A (en) 1977-09-10
JPS54962B2 JPS54962B2 (enExample) 1979-01-18

Family

ID=12160014

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2522576A Granted JPS52108027A (en) 1976-03-09 1976-03-09 Anticarcinogen

Country Status (9)

Country Link
US (1) US4983636A (enExample)
JP (1) JPS52108027A (enExample)
AU (1) AU499475B2 (enExample)
BE (1) BE852283A (enExample)
CA (1) CA1093971A (enExample)
DE (1) DE2710327C3 (enExample)
FR (1) FR2343475A1 (enExample)
GB (1) GB1573965A (enExample)
NL (1) NL172917C (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446001U (enExample) * 1977-09-07 1979-03-30
US5001176A (en) * 1988-09-05 1991-03-19 Chisso Corporation Crystalline polyolefin composition
JP2016128434A (ja) * 2015-01-06 2016-07-14 Ｓｈｉｏｄａライフサイエンス株式会社 天然ベンズアルデヒド水の製造方法、該製造方法によって製造された天然ベンズアルデヒド水、及び、該天然ベンズアルデヒド水を含有する抗腫瘍剤
JP2018008938A (ja) * 2016-06-30 2018-01-18 Ｓｈｉｏｄａライフサイエンス株式会社 バラ科サクラ属に属する植物の葉の抽出液を含有する抗腫瘍剤

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5830032B2 (ja) * 1981-02-18 1983-06-27 呉羽化学工業株式会社 ビフイダス菌の増殖剤
JPS6112623A (ja) * 1984-06-28 1986-01-21 Kaken Pharmaceut Co Ltd エンケフアリナ−ゼ阻害剤
JPS6256423A (ja) * 1985-09-06 1987-03-12 Kaken Pharmaceut Co Ltd 悪液質治療改善剤
US4874780A (en) * 1987-03-11 1989-10-17 Norsk Hydro A.S. Anticancer compounds
AT393221B (de) * 1988-02-03 1991-09-10 Leopold Pharma Gmbh Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken
US5330744A (en) * 1988-11-14 1994-07-19 Sloan-Kettering Institute For Cancer Research Method for increasing sensitivity to chemically induced terminal differentiation
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
US5789189A (en) * 1993-09-24 1998-08-04 The Regents Of The University Of California Inhibition of cyst formation by cytoskeletal specific drugs
DE19508654B4 (de) * 1995-03-13 2006-08-10 Stepan Co., Northfield Tuberkulozides Desinfekionsmittel und dessen Verwendung
CN1378450A (zh) 1999-09-08 2002-11-06 斯隆-凯特林癌症研究院 新型细胞分化剂和组蛋白脱乙酰基酶抑制剂及其使用方法
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
WO2002078451A1 (en) * 2001-03-30 2002-10-10 Premier Botanicals Ltd. Pesticidal compositions from prunus
CA2520611A1 (en) * 2003-04-01 2004-10-21 Memorial Sloan-Kettering Cancer Center Hydroxamic acid compounds and methods of use thereof
JP6898072B2 (ja) * 2015-08-27 2021-07-07 秀行 佐谷 １４−３−３タンパク質活性調節剤
JP6541087B1 (ja) * 2018-10-16 2019-07-10 株式会社ワールドナッツ アーモンドペースト組成物
JP7018531B1 (ja) * 2021-04-30 2022-02-10 潤 齋藤 Ａｘｌ阻害剤
JP7796158B2 (ja) * 2024-03-25 2026-01-08 潤 齋藤 Ｌｉｎ２８ｂ阻害剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2827452A (en) * 1955-05-31 1958-03-18 Univ Minnesota Stabilization of materials

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BIOCHEMICAL JOURNAL=1938 *
TOXICOLOGY=1975 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5446001U (enExample) * 1977-09-07 1979-03-30
US5001176A (en) * 1988-09-05 1991-03-19 Chisso Corporation Crystalline polyolefin composition
JP2016128434A (ja) * 2015-01-06 2016-07-14 Ｓｈｉｏｄａライフサイエンス株式会社 天然ベンズアルデヒド水の製造方法、該製造方法によって製造された天然ベンズアルデヒド水、及び、該天然ベンズアルデヒド水を含有する抗腫瘍剤
JP2018008938A (ja) * 2016-06-30 2018-01-18 Ｓｈｉｏｄａライフサイエンス株式会社 バラ科サクラ属に属する植物の葉の抽出液を含有する抗腫瘍剤

Also Published As

Publication number Publication date
FR2343475B1 (enExample) 1980-04-25
FR2343475A1 (fr) 1977-10-07
AU499475B2 (en) 1979-04-26
AU2307377A (en) 1978-09-14
DE2710327C3 (de) 1981-02-12
CA1093971A (en) 1981-01-20
JPS54962B2 (enExample) 1979-01-18
DE2710327B2 (de) 1980-04-17
NL7702535A (nl) 1977-09-13
BE852283A (fr) 1977-09-09
GB1573965A (en) 1980-08-28
NL172917C (nl) 1983-11-16
NL172917B (nl) 1983-06-16
DE2710327A1 (de) 1977-09-15
US4983636A (en) 1991-01-08

Similar Documents

Publication Publication Date Title
JPS52108027A (en) Anticarcinogen
JPS5283937A (en) Antiphlogistic and analgesic agent containing benzoyl derivatives as e ffective component
JPS5225037A (en) Carcinostatic agent
JPS5236965A (en) Magnetron
JPS51140182A (en) Divesting process of covered wire
JPS5233624A (en) Preparation of leucylnitroagmatines
JPS5242886A (en) Preparation of esoquinoline compounds
JPS5235227A (en) Preparation of filters for adhesives
JPS5246266A (en) Magnetic brake
JPS51136886A (en) New biologica lly active substance, ml-236c, and its preparation
JPS5430185A (en) Mandelic acid derivative and carcinostatic agnet containing the same
JPS5350397A (en) Preparation of 4-hydroxycyclopent-2-ene-1-one
JPS5219652A (en) Preparation of leucylagmatine compounds
JPS5371063A (en) Preparation of 4-(1-9x9-2-isoindolinyl)acetophenone
JPS528665A (en) Additives for preventing bulking
JPS526846A (en) Water turbine
JPS5218834A (en) Long-acting perfumery composition
JPS51132799A (en) Composite superconductive wire-materials
JPS5228541A (en) Lubricated components
JPS5312878A (en) Preparation of cyanopyrazinecarboxyamide and its preparation
JPS5271426A (en) Preparation of ebnzylalcohol derivatives
JPS51132500A (en) High dielectric composed substance
JPS5212195A (en) Preparation of 1,2,5-thiadiazolo(3,4-e)2, 7,1,3,6,8-dithiatetraza-as-in dacene
JPS51150137A (en) Water controller
JPS5271468A (en) Preparation of crystals of 5-amino-4-imidazole-carboxamide